Ohio State University CRS

McCampbell Hall, 4th Floor, 1581 Dodd Drive, Room 427
Columbus, OH 43210-1282
United States of America

https://wexnermedical.osu.edu/infectious-diseases/aids-clinical-trials-unit

Kathy Watson
kathy.watson@osumc.edu
614-293-5856

Susan Koletar
susan.koletar@osumc.edu
614-293-5667

• A5128: US Genomic Sampling
• A5321: Decay of HIV-1 Reservoirs in Participants on Long-Term Antiretroviral Therapy: The ACTG HIV Reservoirs Cohort (AHRC) Study
• A5322: Long-Term Follow-up of Older HIV-infected Adults in the ACTG: Addressing Issues of Aging, HIV Infection and Inflammation (HAILO)
• A5332: REPRIEVE Trial
• A5354: Early ART in Acute HIV
• A5357: A Study of Long-Acting Cabotegravir Plus VRC01LS to Maintain Viral Suppression in HIV-1-Infected Adults
• A5359: The LATITUDE Study
• A5361s: Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE)
• A5366: Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation with Histone Deacetylase Inhibitors
• A5368:Anti-PD-1 Antibody in HBV Infected on Suppressive Antiviral Therapy
• A5401: ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies
• A5371: A Single-Arm, Open-Label, Pilot Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome with Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)
• A5379: B-Enhancement of HBV vaccination in persons living with HIV (BEe-HIVe): Evaluation of HEPLISAV-B